The market doesnt know what a good thing is anymore.
This was a good result. Revenue up 16%, Net Profit up +9%(above consensus), Paying a dividend.
Of course margins are going to be Squeezed in a high inflation environment, what do people expect.
The effects of GLP-1 on Sales are pure speculation and coming from the mouths of shorters and fear-mongers. With another quarter of revenue growth, this fact will be realised by the market and the SP will head north of $30 once again.
Time to buy some more RMD.
All IMO DYOR
Ann: ResMed Announces Results for the First Quarter of FY2024, page-24
-
- There are more pages in this discussion • 52 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add RMD (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$34.66 |
Change
-0.100(0.29%) |
Mkt cap ! $21.25B | |||
| Open | High | Low | Value | Volume |
| $34.65 | $34.82 | $34.53 | $45.12M | 1.301M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 2500 | $34.59 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $34.76 | 632 | 2 |
View Market Depth
| Last trade - 16.10pm 04/10/2024 (20 minute delay) ? |
| RMD (ASX) Chart |